Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOXL vs GSK✓SelectedUSD · GSKSOXL vs GSK performance historyLatest closeAs of-16.39%11/16
Stock and ETF performance explorer

SOXL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-22.1%
GSK return
+47.4%
Excess return
-69.4%
Maximum drawdown
-90.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-16.4%-0.1%-16.3%-16.4%
7D-13.2%-1.3%-11.9%-13.0%
30D-47.9%+2.7%-50.7%-48.4%
3M-66.3%+2.7%-69.1%-66.9%
6M-70.3%+3.3%-73.6%-71.6%
YTD+16.1%+6.5%+9.6%+8.7%
1Y+25.6%+10.7%+14.9%+15.3%
3Y+118.4%+64.4%+54.1%+50.5%
All-22.1%+47.4%-69.4%-52.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling